TLG Capital

TLG Capital is a private investment firm established in 2009 and headquartered in London, specializing in growth capital investments, primarily in Sub-Saharan Africa. The firm is dedicated to empowering entrepreneurs in frontier markets and emphasizes the importance of impact creation alongside financial success. TLG Capital focuses on sectors that benefit from the growing African consumer market, including healthcare, finance, consumer goods, and real estate. Their investment strategy encompasses a range of approaches, including direct minority and majority stake investments, secondary opportunities, and distressed fund restructurings. TLG Africa, a permanent capital investment vehicle, actively seeks board representation and minority protections for its investments. Notable projects include a WHO pre-approved pharmaceutical plant in Uganda and various healthcare facilities in West Africa. TLG Capital's commitment to social and developmental impact has earned it multiple awards, including recognition for significant deals in the private equity sector.